Impact of Breast Cancer Screening on Clinical Medicine
Author Information
Author(s): H.J. de Koning, G.J. van Oortmarssen, B.M. van Ineveld, P.J. van der Maas
Primary Institution: Erasmus Universiteit Rotterdam
Hypothesis
Does nationwide breast cancer screening reduce mortality and affect treatment modalities for women aged 50-70?
Conclusion
Breast cancer screening significantly reduces mortality and shifts treatment from mastectomies to breast conserving therapy.
Supporting Evidence
- Screening is expected to decrease the number of mastectomies by 15%.
- 12% reduction in breast cancer mortality is predicted with bi-annual screening.
- An increase in breast conserving therapy is anticipated as a result of earlier detection.
- Favourable effects of screening outweigh the unfavourable effects.
- Screening will lead to a temporary increase in diagnosed cases due to earlier detection.
Takeaway
Screening for breast cancer helps find it earlier, which means women can get less invasive treatments and live longer.
Methodology
The study used simulation models based on data from screening trials and health care practices in the Netherlands.
Potential Biases
Potential overdiagnosis and overtreatment of non-invasive cancers.
Limitations
The predictions are based on Dutch data and may not apply universally to other countries.
Participant Demographics
Women aged 50-70 in the Netherlands.
Want to read the original?
Access the complete publication on the publisher's website